In a big study, a Merck vaccine prevented early forms of cervical cancer from developing, bolstering hopes that the new product, called Gardasil, could strikea major blowagainst the disease and the sexually transmitted virus that causes it.
In a big study, a Merck (nyse: MRK - news - people ) vaccine prevented early forms of cervical cancer from developing, bolstering hopes that the new product, called Gardasil, could strikea major blowagainst the disease and the sexually transmitted virus that causes it.